麻豆传媒

Public Health & Policy >

Washington Watch

'Dreamland' Author Takes an Opioid Epidemic Trip

Investigative journalist Sam Quinones talks about the crisis

Time to Divorce USPSTF Statements from Coverage Decisions?

First-dollar payment mandate has rob-Peter, pay-Paul consequence

Clinton's Hypothyroid Medication Draws Interest

Candidate is taking Armour Thyroid rather than levothyroxine

MedPAC Looks at Ways to Adjust Misvalued Services

Commission debates grouping CPT codes into families

Q&A: SAMHSA's Acting Administrator

Kana Enomoto on turning around the troubled agency

Election 2016 Snapshot: Medicare

Trump and Clinton offer different visions for Medicare

Safety Net, Teaching Hospitals Call CMS Star Ratings Unfair

Argue scores don't account for factors they can't control

RNC: Docs Protest as Trump Takes Stage

Fatima Fadlalla is an internist and activist

Why We Cover Politics

All politics may be local, but all medicine now has a political side

RNC: Let's Keep Government Out of Healthcare, Price Says

Trump is the right person to do that, according to Georgia lawmaker

FDA Panel Splits on Expanded Jardiance Indication

Questions raised about key trial

301 People Charged With $900 Million in False Medicare Billings

Largest sweep since government fraud team began in 2007

AMA Blasts Medicare Part B Drug Price Plan

Votes to ask CMS to withdraw proposal

AMA Bucks NRA: Backs Waiting Periods, Background Checks

"Stop studying and let's do something"

Drop Ban on Gun Violence Research at CDC, Urges AMA

"We will not stand idly by and watch fellow Americans be slaughtered"

Unapproved Wound Care Products Flood the Market

Expert: Closer regulation could prevent many amputations

Owning a Dog May Help Veterans With PTSD

Small study finds adoption tied to lower depression, loneliness scores

How to Avoid Misdiagnosis

How a patient makes you feel may affect your diagnostic acumen

Opioid Crisis: Scrap Pain as 5th Vital Sign?

Groups call on JC and CMS to re-evaluate policies that could lead to opioid overprescribing

Medical Schools Boost Pain Management Education

In light of opioid epidemic, more schools focus on thoughtful prescribing

FDA Advisory Panel Unmoved by Gepirone Data

Recommends against novel antidepressant; FDA's fairness questioned

Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

Patient Registries See Promise and Challenges Ahead

Physician-driven registries adapt to a changing health system

Diabetic Seniors Lobby for Medicare to Cover CGM Devices

Senate panel highlights glucose control issues facing Medicare patients with diabetes.

Purdue Pulls New OxyContin Application, and Questions Follow

FDA disavows previous requirement for study of abuse-deterrent formulation

House Committee Votes to Defund AHRQ

Attempt to restore funding fails on voice vote

Evolocumab Receives Mixed FDA Review

FDA sees strong efficacy of new injectable heart drug, but questions appropriateness of study population

FDA Okays Stiolto for COPD

Will include black-box warning about increased risk of asthma-related death.

FDA Panel Gets Earful on Homeopathy

Speakers ranged from harsh critics to vocal proponents.

SNUS: Is This a 'Safe' Tobacco Product?

Swedish smokeless tobacco maker wants FDA to soften warning label.

FDA Advisers Unimpressed by Nocdurna

Another setback for nocturia indication

FDA Launches Compounding Advisory Committee

The 14 committee members come from a variety of disciplines.

AstraZeneca's Move to Protect Nexium Market Ruled Legal

"Pay to delay" strategy upheld by court.

Calif. Docs Among Top Billers for Complex Visits

Three California doctors are among the top five nationally in billing for the most complex office visits, according to data released by Medicare and analyzed by ProPublica and KQED.

Top 5 Reasons Why Internists Are Sued

Not properly diagnosing a condition and nonmedical errors such as equipment failure accounted for more than half of the malpractice lawsuits against internists, a study found.

FDA Panel Says Yes to Inhaled Insulin Device

HYATTSVILLE, Md. -- An FDA advisory panel has voted in favor of approving a new inhaled insulin device, Afrezza, as a short-acting treatment to improve glycemic control in both type 1 and type 2 diabetes.

ICD-10 Follies: Watch Where You're Walking

Yes, there's a code for that. To mark the forthcoming move to the ICD-10 coding system, 麻豆传媒 is spotlighting some of those thousands of new codes that might just be getting a bit too granular.

ICD-10 Follies: Struck by an Orca

Yes, there's a code for that. To mark the forthcoming move to the ICD-10 coding system, 麻豆传媒 is spotlighting some of those thousands of new codes that might just be getting a bit too granular.

ICD-10 Follies: The Birds

Yes, there's a code for that. To mark the forthcoming move to the ICD-10 coding system, 麻豆传媒 is spotlighting some of those thousands of new codes that might just be getting a bit too granular.

5 Problems With Mobile Health App Security

No federal agency has the power to properly regulate the fast-growing world of mobile health applications and telehealth systems, researchers noted while outlining several security risks and privacy threats.

鈥�

30